By analyzing the differences in the 23 m6A methylation genes in RAB22A between the high- and low-expression groups of patients with HCC, we observed that the expression levels of all genes in the RAB22A high-expression group were upregulated (Figure 6Y). The gene discussed is RAB22A; the disease is hepatocellular carcinoma.